Effect of glucocorticoid treatment on computed tomography angiography detected large-vessel inflammation in giant-cell arteritis. A prospective, longitudinal study

Medicine (United States)

Volumn 94, Issue 5, 2015, Pages e486-

  Prieto González, Sergio ^a   García Martínez, Ana ^a   Tavera Bahillo, Itziar ^a   Hernández Rodríguez, José ^a   Gutiérrez Chacoff, José ^b   Alba, Marco A ^a   Murgia, Giuseppe ^a   Espígol Frigolé, Georgina ^a   Sánchez, Marcelo ^b   Arguis, Pedro ^b   Cid, Maria C ^a,c  

^a Department of Systemic Autoimmune Diseases ^*  (United States)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOCORTICOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHYLPREDNISOLONE; PREDNISONE;

ABDOMINAL AORTA; ADULT; AGED; AORTA ARCH; ARTERIAL WALL THICKENING; ARTICLE; ASCENDING AORTA; AXILLARY ARTERY; BRACHIOCEPHALIC TRUNK; CAROTID ARTERY; CLINICAL ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTED TOMOGRAPHY SCANNER; CONTRAST ENHANCEMENT; CORTICOSTEROID THERAPY; DESCENDING AORTA; DRUG MEGADOSE; FEMALE; FEMORAL ARTERY; FOLLOW UP; GIANT CELL ARTERITIS; HUMAN; ILIAC ARTERY; LARGE VESSEL VASCULITIS; LONGITUDINAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RENAL ARTERY; SUBCLAVIAN ARTERY; THORACIC AORTA; TREATMENT RESPONSE; VASCULITIS; VERY ELDERLY; ANGIOGRAPHY; AORTA; COMPUTER ASSISTED TOMOGRAPHY; MIDDLE AGED; PATHOPHYSIOLOGY; RADIOGRAPHY; RECURRENT DISEASE;

AGED; AGED, 80 AND OVER; ANGIOGRAPHY; AORTA; FEMALE; GIANT CELL ARTERITIS; GLUCOCORTICOIDS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; TOMOGRAPHY, X-RAY COMPUTED; VASCULITIS;

EID: 84922879064     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000486     Document Type: Article

References (59)

1. Cid MC, Font C, Coll-Vinent B, Grau JM. Large vessel vasculitides. Curr Opin Rheumatol. 1998;10:18-28.
2. Salvarani C, Pipitone N, Versari A, Hunder GG. Clinical features of polymyalgia rheumatica and giant cell arteritis. Nat Rev Rheumatol. 2012;8:509-521.
3. Cid MC, Prieto-Gonzalez S, Arguis P, et al. The spectrum of vascular involvement in giant-cell arteritis: clinical consequences of detrimental vascular remodelling at different sites. APMIS Suppl. 2009:10-20.
4. Prieto-Gonzalez S, Arguis P, Garcia-Martinez A, et al. Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography. Ann Rheum Dis. 2012;71:1170-1176.
5. Prieto-Gonzalez S, Depetris M, Garcia-Martinez A, et al. Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case-control study. Ann Rheum Dis. 2014;73:1388-1392.
6. Blockmans D, de Ceuninck L, Vanderschueren S, et al. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum. 2006;55:131-137.
7. Agard C, Barrier JH, Dupas B, et al. Aortic involvement in recentonset giant cell (temporal) arteritis: a case-control prospective study using helical aortic computed tomodensitometric scan. Arthritis Rheum. 2008;59:670-676.
8. Schmidt WA, Seifert A, Gromnica-Ihle E, et al. Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology (Oxford). 2008;47 (1):96-101.
9. Schmidt WA, Natusch A, Moller DE, et al. Involvement of peripheral arteries in giant cell arteritis: a color Doppler sonography study. Clin Exp Rheumatol. 2002;20:309-318.
10. Aschwanden M, Kesten F, Stern M, et al. Vascular involvement in patients with giant cell arteritis determined by duplex sonography of 2x11 arterial regions. Ann Rheum Dis. 2010;69:1356-1359.
11. Ghinoi A, Pipitone N, Nicolini A, et al. Large-vessel involvement in recent-onset giant cell arteritis: a case-control colour-Doppler sonography study. Rheumatology (Oxford). 2012;51:730-734.
12. Prieto-Gonzalez S, Arguis P, Cid MC. Imaging in vasculitis. Curr Opin Rheumatol. 2015;27:53-62.
13. Espigol-Frigole G, Prieto-Gonzalez S, Alba MA, et al. Advances in the diagnosis of large vessel vasculitis. Rheum Dis Clin North Am. 2015;41:125-140.
14. Evans JM, O'Fallon WM, Hunder GG. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med. 1995;122:502-507.
15. Kermani TA, Warrington KJ, Crowson CS, et al. Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis. Ann Rheum Dis. 2013;72:1989-1994.
16. Mackie SL, Hensor EM, Morgan AW, Pease CT. Should I send my patient with previous giant cell arteritis for imaging of the thoracic aorta? A systematic literature review and meta-analysis. Ann Rheum Dis. 2014;73:143-148.
17. Robson JC, Kiran A, Maskell J, et al. The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK. Ann Rheum Dis. 2013doi: 10.1136/annrheumdis-2013-204113[Epub ahead of print].
18. Garcia-Martinez A, Hernandez-Rodriguez J, Arguis P, et al. Development of aortic aneurysm/dilatation during the followup of patients with giant cell arteritis: a cross-sectional screening of fifty-four prospectively followed patients. Arthritis Rheum. 2008;59:422-430.
19. Garcia-Martinez A, Arguis P, Prieto-Gonzalez S, et al. Prospective long term follow-up of a cohort of patients with giant cell arteritis screened for aortic structural damage (aneurysm or dilatation). Ann Rheum Dis. 2014;73:1826-1832.
20. Evans JM, Bowles CA, Bjornsson J, et al. Thoracic aortic aneurysm and rupture in giant cell arteritis. A descriptive study of 41 cases. Arthritis Rheum. 1994;37:1539-1547.
21. Bongartz T, Matteson EL. Large-vessel involvement in giant cell arteritis. Curr Opin Rheumatol. 2006;18:10-17.
22. Petursdottir V, Nordborg E, Nordborg C. Atrophy of the aortic media in giant cell arteritis. APMIS. 1996;104:191-198.
23. Segarra M, Garcia-Martinez A, Sanchez M, et al. Gelatinase expression and proteolytic activity in giant-cell arteritis. Ann Rheum Dis. 2007;66:1429-1435.
24. Alba MA, Espígol-Frigolé G, Butjosa M, et al. Treatment of largevessel vasculitis. Curr Immunol Rev. 2011;7:435-442.
25. Alba MA, Garcia-Martinez A, Prieto-Gonzalez S, et al. Treatment with angiotensin II receptor blockers is associated with prolonged relapse-free survival, lower relapse rate, and corticosteroid-sparing effect in patients with giant cell arteritis. Semin Arthritis Rheum. 2014;43:772-777.
26. Alba MA, Garcia-Martinez A, Prieto-Gonzalez S, et al. Relapses in patients with giant cell arteritis: prevalence, characteristics, and associated clinical findings in a longitudinally followed cohort of 106 patients. Medicine (Baltimore). 2014;93:194-201.
27. Restrepo CS, Ocazionez D, Suri R, Vargas D. Aortitis: imaging spectrum of the infectious and inflammatory conditions of the aorta. Radiographics. 2011;31:435-451.
28. Zhu FP, Luo S, Wang ZJ, et al. Takayasu arteritis: imaging spectrum at multidetector CT angiography. Br J Radiol. 2012;85:e1282-e1292.
29. Kim SY, Park JH, Chung JW, et al. Follow-up CT evaluation of the mural changes in active Takayasu arteritis. Korean J Radiol. 2007;8:286-294.
30. Aronberg DJ, Glazer HS, Madsen K, Sagel SS. Normal thoracic aortic diameters by computed tomography. J Comput Assist Tomogr. 1984;8:247-250.
31. Lu TL, Rizzo E, Marques-Vidal PM, et al. Variability of ascending aorta diameter measurements as assessed with electrocardiographygated multidetector computerized tomography and computer assisted diagnosis software. Interact Cardiovasc Thorac Surg. 2010;10:217-221.
32. Nuenninghoff DM, Hunder GG, Christianson TJ, et al. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum. 2003;48:3522-3531.
33. Gonzalez-Gay MA, Garcia-Porrua C, Pineiro A, et al. Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a population-based study. Medicine (Baltimore). 2004;83:335-341.
34. Blockmans D, Coudyzer W, Vanderschueren S, et al. Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis. Rheumatology (Oxford). 2008;47:1179-1184.
35. Kermani TA, Matteson EL, Hunder GG, Warrington KJ. Symptomatic lower extremity vasculitis in giant cell arteritis: a case series. J Rheumatol. 2009;36:2277-2283.
36. Czihal M, Piller A, Schroettle A, et al. Outcome of giant cell arteritis of the arm arteries managed with medical treatment alone: cross-sectional follow-up study. Rheumatology (Oxford). 2013;52:282-286.
37. Sujobert P, Fardet L, Marie I, et al. Mesenteric ischemia in giant cell arteritis: 6 cases and a systematic review. J Rheumatol. 2007;34:1727-1732.
38. Scola CJ, Li C, Upchurch KS. Mesenteric involvement in giant cell arteritis. An underrecognized complication? Analysis of a case series with clinicoanatomic correlation. Medicine (Baltimore). 2008;87:45-51.
39. Grant S. Giant cell arteritis, scalp necrosis and myocardial infarction. Intern Med J. 2004;34:138-139.
40. Samson M, Jacquin A, Audia S, et al. Stroke associated with giant cell arteritis: a population-based study. J Neurol Neurosur Psychiatry. 2014doi: 10.1136/jnnp-2014-307614[Epub ahead of print].
41. Zenone T, Puget M. Characteristics of cerebrovascular accidents at time of diagnosis in a series of 98 patients with giant cell arteritis. Rheumatol Int. 2013;33:3017-3023.
42. Kermani TA, Warrington KJ. Lower extremity vasculitis in polymyalgia rheumatica and giant cell arteritis. Curr Opin Rheumatol. 2011;23:38-42.
43. Klein RG, Hunder GG, Stanson AW, Sheps SG. Large artery involvement in giant cell (temporal) arteritis. Ann Intern Med. 1975;83:806-812.
44. Mukhtyar C, Guillevin L, Cid MC, et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis Mar. 2009;68:318-323.
45. Hauenstein C, Reinhard M, Geiger J, et al. Effects of early corticosteroid treatment on magnetic resonance imaging and ultrasonography findings in giant cell arteritis. Rheumatology (Oxford). 2012;51:1999-2003.
46. Fuchs M, Briel M, Daikeler T, et al. The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis. Eur J Nucl Med Mol Imaging. 2012;39:344-353.
47. Prieto-Gonzalez S, Garcia-Martinez A, Arguis P, Cid MC. Early improvement of radiological signs of large-vessel inflammation in giant cell arteritis upon glucocorticoid treatment. Rheumatology (Oxford). 2013;52:1335-1336.
48. Santoro L, D'Onofrio F, Bernardi S, et al. Temporal ultrasonography findings in temporal arteritis: early disappearance of halo sign after only 2 days of steroid treatment. Rheumatology (Oxford). 2013;52:622.
49. Schafer VS, Zwerina J. Biologic treatment of large-vessel vasculitides. Curr Opin Rheumatol. 2012;24:31-37.
50. Fauchald P, Rygvold O, Oystese B. Temporal arteritis and polymyalgia rheumatica. Clinical and biopsy findings. Ann Intern Med. 1972;77:845-852.
51. Achkar AA, Lie JT, Hunder GG, et al. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann Intern Med. 1994;120:987-992.
52. Visvanathan S, Rahman MU, Hoffman GS, et al. Tissue and serum markers of inflammation during the follow-up of patients with giantcell arteritis-a prospective longitudinal study. Rheumatology (Oxford). 2011;50:2061-2070.
53. Hoffman GS, Cid MC, Rendt-Zagar KE, et al. Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial. Ann Intern Med. 2007;146:621-630.
54. Marmursztejn J, Guillevin L, Trebossen R, et al. Churg-Strauss syndrome cardiac involvement evaluated by cardiac magnetic resonance imaging and positron-emission tomography: a prospective study on 20 patients. Rheumatology (Oxford). 2013;52:642-650.
55. Assie C, Janvresse A, Plissonnier D, et al. Long-term follow-up of upper and lower extremity vasculitis related to giant cell arteritis: a series of 36 patients. Medicine (Baltimore). 2011;90:40-51.
56. Tato F, Hoffmann U. Clinical presentation and vascular imaging in giant cell arteritis of the femoropopliteal and tibioperoneal arteries. Analysis of four cases. J Vasc Surg. 2006;44:176-182.
57. McCain GA, Thompson JM. Isolated giant cell arteritis. J Rheumatol. 1978;5:474-476.
58. Cid MC, Cervera R, Font J, et al. Recurrent arterial thrombosis in a patient with giant-cell arteritis and raised anticardiolipin antibody levels. Br J Rheumatol. 1988;27:164-166.
59. Maksimowicz-McKinnon K, Clark TM, Hoffman GS. Takayasu arteritis and giant cell arteritis: a spectrum within the same disease? Medicine (Baltimore). 2009;88:221-226.